Also known as: Analgesics, Painkillers
Pharmacogenetics affects pain management on two fronts: how opioids are activated (or not) and how NSAIDs are cleared. The CYP2D6 gene is central to the opioid story because it converts codeine and tramadol from their inactive forms into their active metabolites. Poor metabolizers get little pain relief; ultrarapid metabolizers can reach dangerous opioid levels on standard doses.
Each link goes to the drug's full pharmacogenetics page with CPIC and FDA phenotype recommendations.
Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.
This page covers the pharmacogenetics of pain medications in general. A Gene2Rx report tells you how your personal genotype interacts with every drug on this page.
Get your report Look up a medicationInformational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.